Fidelity Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Fidelity Investments’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,535,389	Closed	-$137M	–	2779
2017 Q4	$137M	Sell	2,535,389 -1,061,132	-30%	-$58.1M	0.02%	859
2017 Q3	$205M	Sell	3,596,521 -274,761	-7%	-$16.1M	0.02%	673
2017 Q2	$233M	Buy	3,871,282 +3,142,727	+431%	+$179M	0.03%	623
2017 Q1	$39.7M	Buy	+728,555	New	+$35.9M	0.01%	1430

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Fidelity Investments's BIVV Position: Q1 2018 in Review

Fidelity Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 2,535,389 shares — an estimated $137M sold.

Fidelity Investments first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $233M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Fidelity Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Fidelity Investments sold 2,535,389 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $137M.
Fidelity Investments first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Fidelity Investments's Bioverativ Inc. Common Stock position peaked at $233M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Fidelity Investments's 13F filing for Q1 2018, filed 14 May 2018.